Monkey Tumor necrosis factor

Product name: Recombinant (active) mouse TNF alpha protein

Biological activity

Fully active compared to a standard. The ED50 determined by the dose-dependent killing/apoptosis of L-929 cells is 1.12 ng / ml corresponding to a specific activity of 8.93 x 105 IU / mg.

Purity: = 95% SDS-PAGE.

Purity by HPLC> = 95%.

Endotoxin Level: <0.005 Eu / µg

Expression system: HEK 293 cells

Accession: P06804

Protein length: Full length protein

Animal-free: Yes

Free carrier: Yes

Nature: Recombinant

Species: Mouse

Predicted molecular weight: 20 kDa

Amino acids: 57 to 235

Additional information about the sequence: N-terminal glycine

Preparation and storage

Stability and storage

  • Sent at room temperature. Store at room temperature.
  • The information available upon request.
  • This product is an active protein and can elicit a biological response in vivo, handle with caution.


Reconstitute with phosphate-buffered saline. Store the lyophilized form at room temperature. Reconstitute, aliquot, and store at -80 ° C for 12 months or + 4 ° C for 1 week. Avoid repeated freeze-thaw.

Leave a Reply

Your email address will not be published. Required fields are marked *


PD 161570

Properties Related Categories Approved Therapeutics / Drug Candidates, Bioactive Small Molecules Alphabetical Index, Bioactive Small Molecules, Cell Biology, Cell Signaling, and Neuroscience, Quality level: 100 Assay: ≥98% (HPLC) Form: dust mfr. No:  Pfizer® Color: white to off-white Solubility DMSO :> 10 mg / mL Creator: Pfizer Description Packaging 5, 25 mg in a glass bottle […]

Read More


Resume Background Sepsis is a potentially fatal syndrome mediated by an early [eg, tumor necrosis factor-alpha (TNF-α)] and late [high-mobility group box 1 (HMGB-1)] cytokine response to infection. Sepsis-induced acute kidney injury (ARI) is associated with high mortality. C-Fos / activator protein-1 (AP-1) controls the transactivation of pro-inflammatory cytokines through the binding of AP-1 in […]

Read More

AVE 0991

Description AVE 0991 is an orally active, non-peptide angiotensin (1-7) receptor agonist with an IC50 of 21 nM. IC50 and target IC50: 21 ± 35 nM (receptor Ang- (1-7)) In vitro AVE 0991 is a non-peptide compound that evokes Ang- (1-7) -like effects on the endothelium. AVE 0991 and unlabeled Ang- (1-7) compete for high-affinity […]

Read More